paclitaxel has been researched along with EHS Tumor in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (47.06) | 18.2507 |
| 2000's | 5 (29.41) | 29.6817 |
| 2010's | 4 (23.53) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bahadur, D; Banerjee, R; Gogoi, M; Jaiswal, MK; Sarma, HD | 1 |
| Arnold, MA; Chatterjee, M; Gorlick, R; Houghton, PJ; Kolb, EA; Kurmasheva, RT; Maris, JM; Smith, MA; Tong, Z; Williams, TM; Wu, J | 1 |
| Anchoori, RK; Khan, SR; Kostova, MB; Neamati, N; Xu, S; Yamada, R | 1 |
| Ding, Y; Hao, L; Niu, X; Xu, H; Yang, Y; Zhang, Q | 1 |
| Claiborne, A; Credo, RB; Frost, DJ; Gwaltney, SL; Li, Q; Ng, SC; Nukkala, MA; Rosenberg, SH; Sham, HL; Tahir, SK; Warner, RB; Woods, KW; Zielinski Mozny, NA | 1 |
| Fujikawa-Yamamoto, K; Han, JF; Katsuda, S; Matsui, S; Zong, ZP | 1 |
| Chung, WK; Hunter, NR; Mason, KA; Milas, L; Milross, CG; Peters, LJ | 1 |
| Cao, S; Harstrick, A; Rustum, YM; Seeber, S; Vanhoefer, U | 1 |
| Cao, S; Minderman, H; Rustum, YM; Scheper, RJ; Slovak, ML; Tóth, K; Vanhoefer, U | 1 |
| Burger, CJ; Elgert, KD; Mullins, DW | 2 |
| Charnsangavej, C; Hunter, NR; Ke, S; Li, C; Milas, L; Price, JE; Wallace, S; Yu, DF | 1 |
| Boucher, Y; Brekken, C; Griffon-Etienne, G; Jain, RK; Suit, HD | 1 |
| Chang, YG; Fujikawa-Yamamoto, K; Ishikawa, Y; Li, AL; Murakami, M; Yamaguchi, N; Zong, ZP | 1 |
| Barillari, G; Carlei, D; Cereseto, A; Ciccolella, C; Ensoli, B; Monini, P; Palladino, C; Sgadari, C; Stürzl, M; Toschi, E; Yarchoan, R | 1 |
| Daniewski, W; Kobus, M; Kopczacki, P; Krawczyk, E; Łuczak, M | 1 |
| Bissery, MC; Guénard, D; Guéritte-Voegelein, F; Lavelle, F | 1 |
17 other study(ies) available for paclitaxel and EHS Tumor
| Article | Year |
|---|---|
Biocompatibility and therapeutic evaluation of magnetic liposomes designed for self-controlled cancer hyperthermia and chemotherapy.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biocompatible Materials; Cell Line, Tumor; Combined Modality Therapy; Female; Humans; Hyperthermia, Induced; Liposomes; Magnetics; Magnetite Nanoparticles; Materials Testing; Mice; Neoplasms; Paclitaxel; Sarcoma, Experimental; Tissue Distribution | 2017 |
Initial testing (stage 1) of the tubulin binding agent nanoparticle albumin-bound (nab) paclitaxel (Abraxane(®)) by the Pediatric Preclinical Testing Program (PPTP).
Topics: Adult; Albumins; Animals; Caveolin 1; Child; Female; Humans; Immunoenzyme Techniques; Mice; Mice, SCID; Nanoparticles; Osteonectin; Paclitaxel; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sarcoma, Experimental; Tissue Distribution; Tubulin; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2015 |
Biological evaluation of paclitaxel-peptide conjugates as a model for MMP2-targeted drug delivery.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Colony-Forming Units Assay; Drug Delivery Systems; Drug Resistance, Neoplasm; Fibrosarcoma; Humans; Matrix Metalloproteinase 2; Mice; Mice, Nude; Oligopeptides; Paclitaxel; Prodrugs; Sarcoma, Experimental; Xenograft Model Antitumor Assays | 2010 |
The efficacy of abraxane on osteosarcoma xenografts in nude mice and expression of secreted protein, acidic and rich in cysteine.
Topics: Albumin-Bound Paclitaxel; Albumins; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Blotting, Western; Bone Neoplasms; Cell Line, Tumor; Disease Models, Animal; Doxorubicin; Female; Humans; Maximum Tolerated Dose; Mice; Mice, Nude; Osteonectin; Osteosarcoma; Paclitaxel; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Sarcoma, Experimental; Tumor Burden; Xenograft Model Antitumor Assays | 2012 |
Biological activity of A-289099: an orally active tubulin-binding indolyloxazoline derivative.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Apoptosis; Binding Sites; Caspase 3; Caspases; Cell Cycle; Cell Cycle Proteins; Cell Division; Colchicine; Dose-Response Relationship, Drug; Female; Humans; In Situ Nick-End Labeling; Indoles; Mice; Mice, Inbred C57BL; Mitosis; Oxazoles; Paclitaxel; Sarcoma, Experimental; Tubulin; Tumor Cells, Cultured; Vincristine | 2003 |
Phorbol myristate induces apoptosis of taxol-resistant sarcoma cells in vitro.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Caspases; Cell Cycle; Cell Line, Tumor; DNA; Drug Resistance, Neoplasm; Drug Synergism; Flow Cytometry; G1 Phase; Genes, bcl-2; Genes, p53; Male; Mice; Mice, Inbred BALB C; Mitosis; Oncogene Protein p21(ras); Paclitaxel; Polyploidy; Resting Phase, Cell Cycle; S Phase; Sarcoma, Experimental; Survival; Tetradecanoylphorbol Acetate | 2004 |
Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Squamous Cell; Lymphoma; Male; Mice; Mice, Inbred C3H; Mitosis; Neoplasm Transplantation; Neoplasms, Experimental; Paclitaxel; Sarcoma, Experimental | 1996 |
Comparative antitumor efficacy of docetaxel and paclitaxel in nude mice bearing human tumor xenografts that overexpress the multidrug resistance protein (MRP)
Topics: Animals; Antineoplastic Agents, Phytogenic; ATP-Binding Cassette Transporters; Docetaxel; Fibrosarcoma; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Paclitaxel; Sarcoma, Experimental; Taxoids; Transplantation, Heterologous; Tumor Cells, Cultured; Up-Regulation | 1997 |
PAK-104P, a pyridine analogue, reverses paclitaxel and doxorubicin resistance in cell lines and nude mice bearing xenografts that overexpress the multidrug resistance protein.
Topics: Animals; Antineoplastic Agents; ATP-Binding Cassette Transporters; Cyclic P-Oxides; Doxorubicin; Drug Resistance, Neoplasm; Glutathione; Humans; Mice; Mice, Nude; Multidrug Resistance-Associated Proteins; Neoplasm Transplantation; Nicotinic Acids; Paclitaxel; Sarcoma, Experimental; Transplantation, Heterologous; Tumor Cells, Cultured | 1996 |
Tumor growth modulates macrophage nitric oxide production following paclitaxel administration.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cytotoxicity, Immunologic; Interferon-gamma; Macrophages; Male; Mice; Mice, Inbred BALB C; Nitric Oxide; Paclitaxel; Sarcoma, Experimental; Tumor Necrosis Factor-alpha | 1998 |
Antitumor activity of poly(L-glutamic acid)-paclitaxel on syngeneic and xenografted tumors.
Topics: Animals; Carcinoma, Hepatocellular; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; Female; Humans; Liver Neoplasms, Experimental; Mammary Neoplasms, Animal; Mice; Mice, Inbred C3H; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Paclitaxel; Polyglutamic Acid; Sarcoma, Experimental; Taxoids; Transplantation, Heterologous; Transplantation, Homologous; Tumor Cells, Cultured | 1999 |
Paclitaxel enhances macrophage IL-12 production in tumor-bearing hosts through nitric oxide.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents, Phytogenic; Dimerization; Immune Tolerance; Interleukin-12; Lymphocyte Activation; Macrophages; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Nitric Oxide; Paclitaxel; Sarcoma, Experimental; T-Lymphocytes | 1999 |
Taxane-induced apoptosis decompresses blood vessels and lowers interstitial fluid pressure in solid tumors: clinical implications.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Blood Vessels; Brain Neoplasms; Docetaxel; Female; Glioblastoma; Humans; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Paclitaxel; Pressure; Sarcoma, Experimental; Specific Pathogen-Free Organisms; Taxoids; Tumor Cells, Cultured | 1999 |
Involvement of protein kinase C in taxol-induced polyploidization in a cultured sarcoma cell line.
Topics: Animals; Antineoplastic Agents, Phytogenic; Blotting, Western; Carcinogens; Cell Cycle; DNA, Neoplasm; Drug Synergism; Flow Cytometry; Fluorescent Antibody Technique; Mice; Mice, Inbred BALB C; Neoplasm Proteins; Paclitaxel; Polyploidy; Protein Kinase C; Sarcoma, Experimental; Tetradecanoylphorbol Acetate; Tubulin; Tumor Cells, Cultured | 2000 |
Mechanism of paclitaxel activity in Kaposi's sarcoma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Movement; Down-Regulation; Growth Inhibitors; Humans; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Transplantation; Paclitaxel; Proto-Oncogene Mas; Proto-Oncogene Proteins c-bcl-2; Sarcoma, Experimental; Sarcoma, Kaposi; Tumor Cells, Cultured | 2000 |
[Influence of newly synthesized sesquiterpenes--analogs of taxol on multiplication of herpes simplex virus (HSV-1MC) and retrovirus (Mo-MSV)].
Topics: Animals; Antiviral Agents; Cells, Cultured; Herpesvirus 1, Human; Mice; Moloney murine sarcoma virus; Paclitaxel; Retroviridae Infections; Sarcoma, Experimental; Sesquiterpenes; Tumor Virus Infections; Virus Replication | 2001 |
Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue.
Topics: Adenocarcinoma; Alkaloids; Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Intraductal, Noninfiltrating; Colonic Neoplasms; Docetaxel; Female; Leukemia, Experimental; Lung Neoplasms; Male; Mammary Neoplasms, Experimental; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasm Transplantation; Neoplasms, Experimental; Osteosarcoma; Paclitaxel; Pancreatic Neoplasms; Sarcoma, Experimental; Taxoids | 1991 |